報價延遲最少15分鐘:2024/06/16 02:01 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
572.05 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
15.59/24.42
|
|
企業價值
249.89B
|
| 資產負債 |
|
每股賬面淨值
119.24
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
42.86B
|
|
每股收益
113.75
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/06/16 02:01 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%). |